The evolutionary and molecular history of a chikungunya virus outbreak lineage.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
26 Jul 2024
Historique:
received: 16 04 2024
accepted: 08 07 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 26 7 2024
Statut: aheadofprint

Résumé

In 2018-2019, Thailand experienced a nationwide spread of chikungunya virus (CHIKV), with approximately 15,000 confirmed cases of disease reported. Here, we investigated the evolutionary and molecular history of the East/Central/South African (ECSA) genotype to determine the origins of the 2018-2019 CHIKV outbreak in Thailand. This was done using newly sequenced clinical samples from travellers returning to Sweden from Thailand in late 2018 and early 2019 and previously published genome sequences. Our phylogeographic analysis showed that before the outbreak in Thailand, the Indian Ocean lineage (IOL) found within the ESCA, had evolved and circulated in East Africa, South Asia, and Southeast Asia for about 15 years. In the first half of 2017, an introduction occurred into Thailand from another South Asian country, most likely Bangladesh, which subsequently developed into a large outbreak in Thailand with export to neighbouring countries. Based on comparative phylogenetic analyses of the complete CHIKV genome and protein modelling, we identified several mutations in the E1/E2 spike complex, such as E1 K211E and E2 V264A, which are highly relevant as they may lead to changes in vector competence, transmission efficiency and pathogenicity of the virus. A number of mutations (E2 G205S, Nsp3 D372E, Nsp2 V793A), that emerged shortly before the outbreak of the virus in Thailand in 2018 may have altered antibody binding and recognition due to their position. This study not only improves our understanding of the factors contributing to the epidemic in Southeast Asia, but also has implications for the development of effective response strategies and the potential development of new vaccines.

Identifiants

pubmed: 39058744
doi: 10.1371/journal.pntd.0012349
pii: PNTD-D-24-00464
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0012349

Informations de copyright

Copyright: © 2024 Krambrich et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Janina Krambrich (J)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Filip Mihalič (F)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Michael W Gaunt (MW)

Solena Ag, Foster City, California, United States of America.

Jon Bohlin (J)

Infectious Disease Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.

Jenny C Hesson (JC)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Biologisk Myggkontroll, Nedre Dalälvens Utvecklings AB, Gysinge, Sweden.

Åke Lundkvist (Å)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

Xavier de Lamballerie (X)

Unité des Virus Émergents (UVE), Aix-Marseille University-IRD 190-Inserm 1207, Marseille, France.

Cixiu Li (C)

Key Laboratory of Emerging Infectious Diseases in Universities of Shandong, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, China.
Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Weifeng Shi (W)

Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Institute of Virology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

John H-O Pettersson (JH)

Department of Medical Science, Uppsala University Uppsala, Sweden.
Department of Clinical Microbiology and Hospital Hygiene, Uppsala University Hospital, Uppsala, Sweden.
Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.

Classifications MeSH